Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer.

Each year in the United States, nearly 70 000 individuals between the ages of 15 and 40 years are diagnosed with cancer. Although overall cancer survival rates among pediatric and older adult patients have increased in recent decades, there has been little improvement in survival of adolescent and young adult (AYA) cancer patients since 1975 when collected data became adequate to evaluate this issue. In 2006, the AYA Oncology Progress Review Group made recommendations for addressing the needs of this population that were later implemented by the LIVESTRONG Young Adult Alliance. One of their overriding questions was whether the cancers seen in AYA patients were biologically different than the same cancers in adult and/or pediatric patients. On June 9-10, 2009, the National Cancer Institute (NCI) and the Lance Armstrong Foundation (LAF) convened a workshop in Bethesda, MD, entitled "Unique Characteristics of AYA Cancers: Focus on Acute Lymphocytic Leukemia (ALL), Breast Cancer and Colon Cancer" that aimed to examine the current state of basic and translational research on these cancers and to discuss the next steps to improve their prognosis and treatment.

[1]  Kevin K Dobbin,et al.  Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. , 2010, Blood.

[2]  J. Downing,et al.  Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. , 2010, Blood.

[3]  A. Ferrari,et al.  Distinct features of colorectal cancer in children and adolescents , 2010, Cancer.

[4]  H. Valdimarsdottir,et al.  Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women , 2009, Journal of oncology.

[5]  Takashi Akasaka,et al.  Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. , 2009, Blood.

[6]  M. Loh,et al.  JAK mutations in high-risk childhood acute lymphoblastic leukemia , 2009, Proceedings of the National Academy of Sciences.

[7]  A. Bleyer,et al.  Breast cancer before age 40 years. , 2009, Seminars in oncology.

[8]  R. DePinho,et al.  Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice , 2009, Proceedings of the National Academy of Sciences.

[9]  Lisa M. McShane,et al.  Effective Incorporation of Biomarkers into Phase II Trials , 2009, Clinical Cancer Research.

[10]  O. Bernard,et al.  A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin , 2009, Leukemia.

[11]  Christopher B. Miller,et al.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. , 2009, The New England journal of medicine.

[12]  C. Harrison.  Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia , 2009, British journal of haematology.

[13]  C. Bloomfield,et al.  What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. , 2008, Blood.

[14]  K. Wimmer,et al.  Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? , 2008, Human Genetics.

[15]  J. Marks,et al.  Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Simon.  Interpretation of genomic data: questions and answers. , 2008, Seminars in hematology.

[17]  C. Perou,et al.  Epidemiology of basal-like breast cancer , 2008, Breast Cancer Research and Treatment.

[18]  David M. Thomas,et al.  The distinctive biology of cancer in adolescents and young adults , 2008, Nature Reviews Cancer.

[19]  J. Marks,et al.  Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors , 2008, PloS one.

[20]  S. Spunt,et al.  Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Stefania Tommasi,et al.  Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers , 2007, Breast Cancer Research.

[22]  Takashi Akasaka,et al.  Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). , 2007, Blood.

[23]  S. Richards,et al.  Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). , 2007, Blood.

[24]  R. Weinberg,et al.  Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. , 2007, Cancer research.

[25]  S. Richards,et al.  Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials , 2007, Pediatric blood & cancer.

[26]  M. Loh,et al.  Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[28]  Boris Freidlin,et al.  Design issues of randomized phase II trials and a proposal for phase II screening trials. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  C. Benz.  Impact of aging on the biology of breast cancer. , 2005, Critical reviews in oncology/hematology.

[30]  Z. Cohen,et al.  Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma , 2005, Gut.

[31]  P. Sonneveld,et al.  Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands , 2004, Leukemia.

[32]  S. Kakar,et al.  Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival , 2004, Modern Pathology.

[33]  R. Weinberg,et al.  Reconstruction of functionally normal and malignant human breast tissues in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Harrison,et al.  Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia? , 2004, Cancer genetics and cytogenetics.

[35]  Karla Kerlikowske,et al.  Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. , 2003, Journal of the National Cancer Institute.

[36]  J. Cayuela,et al.  Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  C. Harrison,et al.  Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases , 2003, Leukemia.

[38]  Y. Jeng,et al.  Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age , 2003, The British journal of surgery.

[39]  M. Martineau,et al.  The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management , 2001, British journal of haematology.

[40]  P S Gartside,et al.  Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. , 1999, Cancer research.

[41]  S. Gapstur,et al.  Hormone receptor status of breast tumors in black, Hispanic, and non‐Hispanic white women: An analysis of 13,239 cases , 1996, Cancer.

[42]  B. Vogelstein,et al.  Genetic instability occurs in the majority of young patients with colorectal cancer , 1995, Nature Medicine.

[43]  M. S. Patel,et al.  An introduction to meta-analysis. , 1989, Health Policy.

[44]  M. Mccracken.  Clinical trials in oncology. , 1982, Clinical oncology.

[45]  Claire Schwab,et al.  Acute lymphoblastic leukaemia. , 2011, Methods in molecular biology.

[46]  J. Downing,et al.  Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. , 2010, Blood.

[47]  Takashi Akasaka,et al.  t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). , 2008, Blood.

[48]  H. Lynch,et al.  Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management , 2007, Familial Cancer.

[49]  D. Proia,et al.  Reconstruction of human mammary tissues in a mouse model , 2006, Nature Protocols.

[50]  M Richard Simon,et al.  Design and Analysis of DNA Microarray Investigations , 2004 .

[51]  L. V. Rubinstein.  Therapeutic studies. , 2000, Hematology/oncology clinics of North America.